Area of research
Genetics · Molecular Biology
Research interest
Research interests include BRCA gene mutations in cancer, Nutrition, Genetics, and Disease, CRISPR and Genetic Engineering, and Genetics, Bioinformatics, and Biomedical Research.
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
Association of the <scp> <i>CHEK2</i> </scp> c. <scp>1100delC</scp> variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variants
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk
10-year performance of four models of breast cancer risk: a validation study
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study
Alcohol consumption, cigarette smoking, and familial breast cancer risk: findings from the Prospective Family Study Cohort (ProF-SC)
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool
Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC)
Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk
Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers
Preferences for in‐person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study
Assessing patient readiness for personalized genomic medicine
A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genes
Dietary isoflavone intake and all‐cause mortality in breast cancer survivors: The Breast Cancer Family Registry
Pubertal development in girls by breast cancer family history: the LEGACY girls cohort